Leavitt: reforms will improve oversight and openness at FDA.
Health and Human Services Secretary Mike Leavitt says drug safety reforms at the Food and Drug Administration will improve openness and oversight and will enhance the agency's independence. In keeping with this vision, the FDA will create a new independent Drug Safety Oversight Board to oversee the management of drug safety issues and will provide emerging information to doctors and patients about the risks and benefits of medicines. For more information www.fda.gov/cder/drugsafety.htm
D000288:Administrative Personnel; D026683:Advisory Committees / Q000458:organization & administration; D009936:Organizational Innovation; D011358:Product Surveillance, Postmarketing; D014481:United States; D014483:United States Dept. of Health and Human Services; D014486:United States Food and Drug Administration / Q000458:organization & administration*